Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study.
已完结
10
由 123 发布于 2026/8/10 16:23:16
DOI:10.1016/j.eclinm.2024.102623
作者：Zhihao Lu,?Li Kong,?Buhai Wang,?Junye Wang,?Lianke Liu,?Yongqian Shu,?Lei Yang,?Guogui Sun,?Guochun Cao,?Yinghua Ji,?Tongjian Cui,?Hu Liu,?Wensheng Qiu,?Na Li,?Gaofeng Li,?Hui Luo,?Xinfang Hou,?Yanqia
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/j.eclinm.2024.102623
作者：Zhihao Lu,?Li Kong,?Buhai Wang,?Junye Wang,?Lianke Liu,?Yongqian Shu,?Lei Yang,?Guogui Sun,?Guochun Cao,?Yinghua Ji,?Tongjian Cui,?Hu Liu,?Wensheng Qiu,?Na Li,?Gaofeng Li,?Hui Luo,?Xinfang Hou,?Yanqia
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/j.eclinm.2024.102623
Elsevier
应助信息
9小时前
tao33
c2f56d7f949411f19901208810ba6e4f.pdf
已采纳
9小时前
Book学术机器人
2026/8/10 16:23:16
未找到该文献，机器人已退出，请等待人工下载
2026/8/10 16:23:16
Book学术AI机器人收到请求，开始寻找文献
2026/8/10 16:23:16
已向机器人发送请求
9小时前
123
发布求助
其它数据库
De Gruyter
京公网安备 11010802042870号
